Last reviewed · How we verify
NCT04415684
Projected Peripheral Defocus Using a Wearable Device
NA trial testing Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.) in Myopia in 26 participants. Completed in 20 August 2020.
20 August 2020
Quick facts
| Lead sponsor | Kubota Vision Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 29 June 2020 |
| Primary completion | 20 August 2020 |
| Estimated completion | 20 August 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
- No Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
Conditions studied
- Myopia — all drugs for Myopia →
Sponsor
Kubota Vision Inc. — full company profile →
Who can join
Adults 18 to 35, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery utilizing a wearable device will stimulate physiological changes similar to those in the literature.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04415684
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other Kubota Vision Inc. trials
Trials by the same sponsor.
- NCT06085430 — Kubota Glass Parameter Refinement Study · NA · completed
- NCT04499703 — Evaluation of the Retinal Health Monitoring System Thickness Module · completed
- NCT04388020 — Effects of Projected Peripheral Defocus on Ocular Biometrics · NA · completed
- NCT04169802 — Study Evaluating Retinal Health Monitoring System Visual Acuity Module. · completed
- NCT03772665 — Safety and Efficacy of Emixustat in Stargardt Disease · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04415684 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kubota Vision Inc.
- Last refreshed: 20 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04415684.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing